+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Hormonal Contraception Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767306
  • Report
  • 62 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Agile Therapeutics Inc
  • Bayer AG
  • Chemo Espana SA
  • Johnson & Johnson
  • Lupin Ltd
  • Medicines360
  • MORE
The global clinical trial report- “2019 Hormonal Contraception Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Hormonal Contraception. It presents in-depth analysis of Hormonal Contraception clinical trials across markets and companies. The research work is for providing complete understanding into trends in Hormonal Contraception.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Hormonal Contraception clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Hormonal Contraception

The research work is prepared through extensive and continuous research on Hormonal Contraception trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Hormonal Contraception patients are identified
  • The report includes panorama of Hormonal Contraception clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Hormonal Contraception clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agile Therapeutics Inc
  • Bayer AG
  • Chemo Espana SA
  • Johnson & Johnson
  • Lupin Ltd
  • Medicines360
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Hormonal Contraception Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Hormonal Contraception Clinical Trials by Region
2.2.2 Average Enrollment of Hormonal Contraception Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Hormonal Contraception Treatment, 2019

3. Region wise Hormonal Contraception Clinical Trials
3.1 Asia Pacific Hormonal Contraception Clinical Trials by Country
3.2 Europe Hormonal Contraception Clinical Trials by Country
3.3 North America Hormonal Contraception Clinical Trials by Country
3.4 Middle East and Africa Hormonal Contraception Clinical Trials by Country
3.5 South and Central America Hormonal Contraception Clinical Trials by Country

4. Hormonal Contraception Clinical Trial Trends
4.1 Start Year wise Hormonal Contraception Clinical Trials
4.2 Phase wise Hormonal Contraception Clinical Trials
4.3 Trial Status wise Hormonal Contraception Clinical Trials
4.4 Trial Type wise Hormonal Contraception Clinical Trials

5. Hormonal Contraception Average Enrollment Trends
5.1 Average Enrollment in Hormonal Contraception Trials by Year
5.2 Average Enrollment in Hormonal Contraception Trials by Phase
5.3 Average Enrollment in Hormonal Contraception Trials by Status
5.4 Average Enrollment in Hormonal Contraception Trials by Type of Trial

6. Companies Participating in Hormonal Contraception Clinical Trials
6.1 Hormonal Contraception Trials by Sponsor Type
6.2 Hormonal Contraception Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Hormonal Contraception Trials- Phase 1
7.2 Hormonal Contraception Trials- Phase 2
7.3 Hormonal Contraception Trials- Phase 3
7.4 Hormonal Contraception Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Hormonal Contraception Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Hormonal Contraception Clinical Trials and Enrolment
Figure 5: Europe - Country wise Hormonal Contraception Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Hormonal Contraception Clinical Trials and Enrolment
Figure 7: North America - Country wise Hormonal Contraception Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Hormonal Contraception Clinical Trials and Enrolment
Figure 9: Hormonal Contraception Clinical Trials by Phase
Figure 10: Hormonal Contraception Clinical Trials by Trial Status
Figure 11: Hormonal Contraception Clinical Trials by Type
Figure 12: Hormonal Contraception Clinical Trials by Sponsor Type
Figure 13: Hormonal Contraception Clinical Trials by Leading Sponsors
Figure 14: Hormonal Contraception Average Enrollment by Phase
Figure 15: Hormonal Contraception Average Enrollment by Trial Status
Figure 16: Hormonal Contraception Average Enrollment by Type
Figure 17: Hormonal Contraception- Average Enrolment by Type of Sponsors
Figure 18: Hormonal Contraception- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Hormonal Contraception Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Hormonal Contraception Clinical Trials and Enrolment
Table 5: Europe - Country wise Hormonal Contraception Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Hormonal Contraception Clinical Trials and Enrolment
Table 7: North America - Country wise Hormonal Contraception Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Hormonal Contraception Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Hormonal Contraception Average Enrollment by Phase
Table 15: Hormonal Contraception Average Enrollment by Trial Status
Table 16: Hormonal Contraception Average Enrollment by Type
Table 17: Hormonal Contraception- Average Enrolment by Type of Sponsors
Table 18: Hormonal Contraception- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Agile Therapeutics Inc
  • Bayer AG
  • Chemo Espana SA
  • Johnson & Johnson
  • Lupin Ltd
  • Medicines360
  • Merck & Co Inc
  • Mylan NV
  • Pfizer Inc
  • Teva Pharmaceutical Industries Ltd
Note: Product cover images may vary from those shown
Adroll
adroll